|
We are currently conducting CNS studies for the treatments of Alzheimer’s Disease (AD), Diabetic Peripheral Neuropathy (DPN), Epilepsy, Multiple Sclerosis (MS), and Parkinson’s Disease (PD).
Please click on the links to the right for more information on our current enrolling studies.
Alzheimer's Disease (ELN301/302):
This research study is for patients 50-88 years of age diagnosed with probable mild to moderate Alzheimer's disease. You must have a caregiver that is willing to be involved in the study. This study lasts 83 weeks with 15 visits. You will receive 6 infusions every 13 weeks. This research study compares the safety and effectiveness of 3 doses of an investigational drug to placebo. The investigational drug is aimed at slowing the progression of the disease. There is no cost to participate and the patient participation is voluntary. There is some reimbursement for time and travel available. Contact Clinical Trials, Inc. at 501-227-6179 to see if you or a loved one might qualify. For email inquiries, contact info@clinicaltrialsinc.com.
Return to the list of our services
Epilepsy (Lu13181A):
This research study is for patients diagnosed with Epilepsy currently treated with Carbamazepine (generic, Tegretol, Carbatrol, Epitol or Equetro) 1200-2000mg per day. This research study has a 27-day lead-in period, confinement (up to 7 days, 6 nights), and a 28-day follow-up period. This research study is evaluating the safety and tolerability of an investigational drug (IV Carbamazepine) as short-term replacement of oral carbamazepine. There is no cost to participate and the patient participation is voluntary. There may be some reimbursement for time and travel available. Contact Clinical Trials, Inc. at 501-227-6179 to see if you or a loved one might qualify. For email inquiries, contact info@clinicaltrialsinc.com
Return to the list of our services
Epilepsy (A1096):
This research study is for people 18-65 years of age diagnosed with epilepsy with partial-onset seizures. Currently taking 1-3 antiepileptic drugs. Volunteers are needed to participate in this clinical research study of an approved medication for add-on treatment of epilepsy. The study up to 19 weeks with at least 7 visits. You will have a Visual Field Test performed during the study. There is no cost to participate and the participation is voluntary. There is some reimbursement for time and travel available. After you complete the study, epilepsy medications prescribed by the study doctor will be provided to you at no cost for six months. Contact Clinical Trials, Inc. at 501-227-6179 to see if you might qualify. For email inquiries, contact info@clinicaltrialsinc.com
Return to the list of our services
Epilepsy (SP902/904):
This study is for patients 16-70 years of age diagnosed with epilepsy with partial-onset seizures with or without secondary generalization. Must be on a stable dose (28 days) of 1 or 2 AED's (anti-epileptic drugs). Must weigh >88lbs and cannot have been in any other trial in the last 2 months. This study lasts up to 30 weeks with visits every 1-4 weeks with a total of up to 14 clinic visits and a possible extension study lasting 2 years. This study tests the effectiveness and safety of an investigational drug as monotherapy (other AEDs will be discontinued). There is no cost to participate and the patient participation is voluntary. There is some reimbursement for time and travel available. Contact Clinical Trials, Inc. at 501-227-6179 to see if you or a loved one might qualify. For email inquiries, contact info@clinicaltrialsinc.com.
Return to the list of our services
Epilepsy (A1194):
This research study is for people 18+ years of age diagnosed with epilepsy with partial-onset seizures. If you are currently taking 1-3 antiepileptic drugs and still having on-going seizures (6 seizures in 8 weeks), you may qualify. Volunteers are needed to participate in this clinical research study of an investigational medication for add-on treatment of epilepsy. The study lasts up to 23 weeks with approximiately 8 visits. There will be no cost to partcipate in the study and the participation is completely voluntary. There may be reimbursement for time and travel available. To see if you qualify, contact Clinical Trials, Inc at 501-227-6179. For email inquiries, contact info@clinicaltrialsinc.com
Return to the list of our services
Parkinson's (PO4938):
This research study is for patients diagnosed with Parkinson's disease at 30 years of age or older. Must be taking carbidopa-levodopa (Sinemet) and on a stable dose for 4 weeks. Must be experiencing "off" periods for at least 2 hours during the day. Cannot have had a pallidotomy or deep brain stimulation surgery for Parkinson's. This research study is approximately 4 months with about 9 office visits. This research study is evaluationg the safety and effectiveness of an investigational drug which may reduce "off" periods. There is no cost to participate and the patient/caregiver participation is voluntary. There may be some reimbursement for time and travel available. Contact Clinical Trials, Inc. at 501-227-6179 to see if you or a loved one might qualify. For email inquiries, contact info@clinicaltrialsinc.com
Return to the list of our services
|
